Diazepam binding inhibitor and the endocrine pancreas
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 30 (12) , 1391-1398
- https://doi.org/10.1016/s0028-3908(11)80007-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Immunohistochemical localization of porcine diazepam-binding inhibitor (DBI) to rat endocrine pancreasCell and tissue research, 1991
- Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreasRegulatory Peptides, 1990
- Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channelsNature, 1989
- Diazepam binding inhibitor-like immunoreactivity(51–70): distribution in human brain, spinal cord and peripheral tissuesBrain Research, 1989
- Isolation and characterization of porcine diazepam‐binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin releaseEuropean Journal of Biochemistry, 1988
- Octadecaneuropeptide, benzodiazepine ligand, -like immunoreactivity in rat central nervous system, plasma and peripheral tissuesNeuroscience Letters, 1986
- Effects of glucose and arginine on the release of immunoreactive somatostatin from the isolated perfused rat pancreasFEBS Letters, 1978
- Cyclic nucleotides in pancreatic islets. Tolbutamide- and arginine-induced insulin releaseDiabetes, 1976
- Structure and Metabolism of the Pancreatic Islets in Streptozotocin Treated Guinea PigsHormone and Metabolic Research, 1970
- NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCEThe Lancet, 1964